Hypromellose Acetate Succinate Market to Reach USD 61.7 Million by 2031 | Key Trends, Growth Outlook & Competitive Insights Global Hypromellose Acetate Succinate (HPMCAS) market is entering a phase of sustained expansion driven by pharmaceutical innovation and rising demand for advanced drug delivery systems. Valued at USD 42.4 million in 2024, the market is projected to grow from USD 44.8 million in 2025 to USD 61.7 million by 2031, reflecting a CAGR of 5.6%. As drug manufacturers pursue enhanced bioavailability and controlled-release formulations, HPMCAS continues to solidify its role as a critical excipient in next-generation therapeutics. Access the full report at https://www.24lifesciences.com/hypromellose-acetate-succinate-market-8043